Severe Oral Mucosal Ulceration Associated with Oral Bisphosphonate Use: The Importance of Imparting Proper Instructions on Medication Administration and Intake

Oral bisphosphonates are approved for the treatment of bone loss associated with several conditions including postmenopausal osteoporosis. Although generally well tolerated, adverse effects such as gastroesophageal reflux and oesophageal and peptic ulceration may occur. Oral mucositis and ulceration...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandran, Manju, Zeng, Wanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969094/
https://www.ncbi.nlm.nih.gov/pubmed/33777146
http://dx.doi.org/10.1155/2021/6620489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969094/
https://www.ncbi.nlm.nih.gov/pubmed/33777146
http://dx.doi.org/10.1155/2021/6620489

Ejemplares similares